Surgical Innovations GroupLSE:SUN Current Ratio is 1.48 as of Dec. 2025, which is 43% below its 10-year median of 2.58. The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Surgical Innovations Group ranks worse than 76.49% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Surgical Innovations Group's current ratio for the quarter that ended in Dec. 2025 was 1.48.
Surgical Innovations Group has a current ratio of 1.48. It generally indicates good short-term financial strength.
The historical rank and industry rank for Surgical Innovations Group's Current Ratio or its related term are showing as below:
LSE:SUN'
s Current Ratio Range Over the Past 10 Years
Min: 1.48 Med: 2.58 Max: 3.79
Current: 1.48
During the past 13 years, Surgical Innovations Group's highest Current Ratio was 3.79. The lowest was 1.48. And the median was 2.58.
LSE:SUN's Current Ratio is ranked worse than 76.49% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs LSE:SUN: 1.48
Surgical Innovations Group (LSE:SUN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Surgical Innovations Group Current Ratio Related Terms
Surgical Innovations Group Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:SUN vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Surgical Innovations Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a Current Ratio of 1.48 as of Dec. 2025. This is 43% below median its historical median of 2.58. Over the past decade, Surgical Innovations Group's Current Ratio has ranged from 1.48 to 3.79. According to the industry distribution chart, Surgical Innovations Group ranks #654 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 76.5%.
Is Surgical Innovations Group's Current Ratio too high?
Surgical Innovations Group's current Current Ratio of 1.48 is 43% below median its 10-year median of 2.58. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 3.79. The Medical Devices & Instruments industry median Current Ratio is 2.49. Surgical Innovations Group's value of 1.48 is 40.6% below this industry median. Based on the distribution chart, Surgical Innovations Group ranks #654 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Surgical Innovations Group's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #654 out of 855 companies for Current Ratio. This places Surgical Innovations Group in the lower half of its industry. The industry median Current Ratio is 2.49. Surgical Innovations Group's value of 1.48 is 40.6% below this benchmark. Historically, Surgical Innovations Group's own Current Ratio has ranged from 1.48 to 3.79 over the past decade. While the company's 10-year median is 2.58 vs. the industry median of 2.49, Surgical Innovations Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current Current Ratio of 1.48 is 40.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current Current Ratio is 1.48, which is 43% below median its own 10-year median of 2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.00 — trading 52.5% below its estimated fair value. The current Current Ratio is 1.48, which is 43% below median its 10-year median of 2.58 and 40.6% below the Medical Devices & Instruments industry median of 2.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Current Ratio is 1.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 